Related Experiment Videos
Metabolic abnormalities in impaired glucose tolerance
1Department of Medicine, Physiology and Pharmacology, University of Rochester School of Medicine, NY 14642, USA.
Metabolism: Clinical and Experimental
|January 24, 1998
Summary
Impaired glucose tolerance (IGT) is a pre-diabetic state characterized by high blood sugar after meals. Key issues include reduced insulin secretion and increased glucose production, offering insights into diabetes development.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Pathogenesis
Background:
- Impaired glucose tolerance (IGT) signifies postprandial hyperglycemia, a precursor to diabetes mellitus (DM).
- IGT exhibits many metabolic abnormalities found in DM, aiding in understanding diabetes pathogenesis.
Purpose of the Study:
- To elucidate the metabolic defects underlying impaired glucose tolerance.
- To investigate the roles of insulin resistance and impaired insulin secretion in IGT.
Main Methods:
- Analysis of glucose metabolism markers, including fasting and postprandial glucose levels.
- Assessment of insulin and glucagon secretion dynamics.
- Evaluation of endogenous glucose production and disposal rates.
Main Results:
- Impaired early insulin release is a consistent defect in IGT.
- Insulin resistance, often linked to obesity or inactivity, is frequently observed.
- Postprandial hyperglycemia in IGT results from inadequate suppression of hepatic glucose release, driven by impaired insulin and glucagon suppression.
Conclusions:
- IGT is characterized by impaired insulin secretion and increased hepatic glucose production.
- Understanding IGT's pathophysiology provides critical insights into the development of type 2 diabetes.
- Early identification and management of IGT are crucial for diabetes prevention.